文献速递类风湿关节炎

衰弱与类风湿关节炎退伍军人癌症发生及癌症相关死亡风险的关联

Associations of Frailty With the Risk of Incident Cancer and Cancer-Related Mortality in Veterans With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-08-26

该回顾性队列研究基于退伍军人事务部类风湿关节炎登记库(2002-2023),纳入2723例患者,使用退伍军人衰弱指数(VA-FI)将基线衰弱状态分为健壮、衰弱前期和衰弱。研究发现衰弱前期和衰弱与癌症发生率显著升高独立相关,但整体衰弱与癌症相关死亡率无显著关联。

要点

  • 衰弱前期和衰弱与类风湿关节炎患者癌症发生率升高独立相关。
  • 衰弱与癌症相关死亡率之间无显著关联。
  • 衰弱状态可能有助于识别类风湿关节炎中恶性肿瘤高风险患者。

核心结论

  • 衰弱与类风湿关节炎患者癌症发生率升高独立相关,可能有助于识别恶性肿瘤高风险患者。

研究设计与样本

  • 回顾性队列研究,分析退伍军人事务部类风湿关节炎登记库(2002-2023)数据,共纳入2723例符合条件患者。
  • 基线使用退伍军人衰弱指数(VA-FI)将衰弱状态分为健壮(VA-FI <0.10)、衰弱前期(VA-FI 0.11-0.20)和衰弱(VA-FI >0.20)。
  • 采用竞争风险模型评估癌症发生和癌症相关死亡,调整人口学、生活方式、类风湿关节炎特征、用药和合并症。

主要发现

  • 年龄调整后癌症发生率每1000人年分别为健壮12.3、衰弱前期15.5、衰弱19.9。
  • 完全调整模型中,衰弱前期与癌症发生风险升高显著相关(sHR 1.37,95% CI 1.02-1.84)。
  • 完全调整模型中,衰弱与癌症发生风险升高显著相关(sHR 1.83,95% CI 1.23-2.71)。
  • 癌症相关死亡率每1000人年分别为健壮7.8、衰弱前期10.6、衰弱9.8,整体衰弱与癌症相关死亡无显著关联。

关键数值与推荐

  • 衰弱状态分类标准:健壮VA-FI <0.10,衰弱前期VA-FI 0.11-0.20,衰弱VA-FI >0.20。
  • 癌症发生风险:衰弱前期sHR 1.37(95% CI 1.02-1.84),衰弱sHR 1.83(95% CI 1.23-2.71)。

临床怎么用

  • 在类风湿关节炎患者中评估衰弱状态可能有助于识别癌症高风险个体,从而加强癌症筛查和监测。

局限性

  • 本研究为回顾性队列研究,可能存在残余混杂。
  • 研究人群以男性退伍军人为主(87.6%),结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study investigated the association between frailty and cancer incidence and mortality in patients with rheumatoid arthritis (RA). It aimed to identify how frailty influences cancer risk and cancer-specific outcomes. METHODS: This retrospective cohort study analyzed data from the Veterans' Affairs Rheumatoid Arthritis Registry (2002-2023). Frailty status was categorized at baseline using the Veterans Affairs Frailty Index (VA-FI): robust (VA-FI <0.10), prefrail (VA-FI 0.11-0.20), and frail (VA-FI >0.20). Cancer incidence and cancer-related deaths were evaluated using competing risk models, adjusting for demographics, lifestyle factors (eg, smoking), RA characteristics (eg, seropositivity, Disease Activity Score-28), medication use, and comorbidities. We additionally studied domain-specific frailty exposures and linear frailty modeling in sensitivity analyses. RESULTS: A total of 2,723 individuals met eligibility criteria (mean age: 63.8 ± 11.2 years; 87.6% male; 15.4% Black). Age-adjusted cancer incidence rates per 1,000 person-years were 12.3 (robust), 15.5 (prefrail), and 19.9 (frail). In fully adjusted models, prefrailty (subdistribution hazard ratio [sHR] 1.37, 95% confidence interval [CI] 1.02-1.84) and frailty (sHR 1.83, 95% CI 1.23-2.71) were significantly associated with higher cancer incidence. Cancer-related mortality rates were 7.8 (robust), 10.6 (prefrail), and 9.8 (frail) per 1,000 person-years, with no significant associations for overall frailty. Domain-specific and sensitivity analyses were consistent with these findings. CONCLUSION: Frailty was independently associated with increased cancer incidence in RA, suggesting frailty may help identify patients at higher risk for malignancy.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Bansal B, Baraff A, Wysham K, et al. Associations of Frailty With the Risk of Incident Cancer and Cancer-Related Mortality in Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2026. PMID: 42655929. doi:10.1002/acr.80147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。